par Klastersky, Jean
Référence Current opinion in oncology, 18, 4, page (316-320)
Publication Publié, 2006-07
Article révisé par les pairs
Résumé : Humanized monoclonal antibodies represent a recent and very significant addition to the anticancer armamentarium. With improved therapeutic strategies due to these agents, however, there are also various, sometimes unexpected, side effects.

Documents en relation

DI-fusion